Rheumatologic manifestations during chronic viral hepatitis C.
Kchir H, Kaffel D, Cherif D, Hamdi W, Maamouri N.
Tunis Med. 2019 Nov;97(11):1251-1257.
Viral hepatitis C.
Czepiel J, Biesiada G, Mach T.
Pol Arch Med Wewn. 2008 Dec;118(12):734-40.
Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study.
Doica IP, Florescu DN, Oancea CN, Turcu-Stiolica A, Subtirelu MS, Dumitra G, Rogoveanu I, Gheonea DI, Ungureanu BS.
Int J Environ Res Public Health. 2021 Apr 1;18(7):3694. doi: 10.3390/ijerph18073694.
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel.
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
Chronic Hepatitis C Infection in Children.
Pham YH, Rosenthal P.
Adv Pediatr. 2016 Aug;63(1):173-94. doi: 10.1016/j.yapd.2016.04.019.
[Chronic viral hepatitis C. Part 1. General considerations].
Conte VP.
Arq Gastroenterol. 2000 Jul-Sep;37(3):187-94. doi: 10.1590/s0004-28032000000300010.
Chronic Hepatitis C and Direct Acting Antivirals.
Westerhoff M, Ahn J.
Surg Pathol Clin. 2018 Jun;11(2):287-296. doi: 10.1016/j.path.2018.02.002. Epub 2018 Mar 26.
Viral hepatitis.
Alter H.
Hepatology. 2006 Feb;43(2 Suppl 1):S230-4. doi: 10.1002/hep.21030.
Chronic viral hepatitis C micro-elimination program using telemedicine in Guigang city.
Lv R, Lu Y, Xiang W, Meng M, Li S.
J Viral Hepat. 2024 Apr;31(4):208-215. doi: 10.1111/jvh.13922. Epub 2024 Feb 7.
Editorial: chronic hepatitis C with metabolic dysfunction-associated fatty liver disease - a model for adoption of Sustainable Development Goal 3.
Ayonrinde O, Goodheart R.
Aliment Pharmacol Ther. 2023 Jan;57(2):270-271. doi: 10.1111/apt.17270. Epub 2022 Dec 5.
